(-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of TRAF1 mRNA CTD PMID:23649840 1'-acetoxychavicol acetate multiple interactions EXP 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of TRAF1 protein] CTD PMID:15905586 1,2-dichloroethane increases expression ISO RGD:1614413 6480464 ethylene dichloride results in increased expression of TRAF1 mRNA CTD PMID:28960355 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of TRAF1 mRNA CTD PMID:14699072 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of TRAF1 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of TRAF1 mRNA], Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of TRAF1 protein] CTD PMID:14761676 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1614413 6480464 Tetrachlorodibenzodioxin affects the expression of TRAF1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1596290 6480464 Tetrachlorodibenzodioxin results in increased expression of TRAF1 mRNA CTD PMID:19520675 , PMID:32109520 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1614413 6480464 tetrabromobisphenol A results in increased expression of TRAF1 mRNA CTD PMID:25172293 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 4-OH-2' more ... CTD PMID:14761676 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of TRAF1 mRNA, Triiodothyronine results in increased expression of TRAF1 protein CTD PMID:14761676 3-methylcholanthrene increases expression ISO RGD:1614413 6480464 Methylcholanthrene results in increased expression of TRAF1 mRNA CTD PMID:29554273 4-hydroxyphenyl retinamide multiple interactions EXP 6480464 Fenretinide inhibits the reaction [TNF protein results in increased expression of TRAF1 protein] CTD PMID:16230421 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of TRAF1 protein CTD PMID:16230421 4-nitroquinoline N-oxide increases expression ISO RGD:1614413 6480464 4-Nitroquinoline-1-oxide results in increased expression of TRAF1 mRNA CTD PMID:22561872 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TRAF1 mRNA CTD PMID:27153756 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of TRAF1 mRNA CTD PMID:20458559 arsenous acid increases expression ISO RGD:1596290 6480464 Arsenic Trioxide results in increased expression of TRAF1 mRNA CTD PMID:19730151 atrazine affects methylation ISO RGD:1596290 6480464 Atrazine affects the methylation of TRAF1 gene CTD PMID:28931070 bathocuproine disulfonic acid multiple interactions EXP 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA], bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA]] CTD PMID:15477007 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of TRAF1 mRNA CTD PMID:20064835 benzo[a]pyrene increases methylation EXP 6480464 Benzoapyrene results in increased methylation of TRAF1 3' UTR CTD PMID:27901495 benzoates increases expression EXP 6480464 Benzoates analog results in increased expression of TRAF1 mRNA CTD PMID:29472718 berberine increases expression EXP 6480464 Berberine results in increased expression of TRAF1 protein CTD PMID:20656010 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of TRAF1 mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1596290 6480464 bisphenol A affects the expression of TRAF1 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:1596290 6480464 bisphenol A results in decreased methylation of TRAF1 gene CTD PMID:28505145 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of TRAF1 mRNA CTD PMID:26485663 cannabidiol increases expression ISO RGD:1614413 6480464 Cannabidiol results in increased expression of TRAF1 mRNA CTD PMID:21542829 carbon nanotube decreases expression ISO RGD:1614413 6480464 Nanotubes more ... CTD PMID:25554681 carmustine decreases expression EXP 6480464 Carmustine results in decreased expression of TRAF1 mRNA CTD PMID:15980968 cholesterol increases expression ISO RGD:1596290 6480464 Cholesterol analog results in increased expression of TRAF1 mRNA CTD PMID:19477266 cisplatin multiple interactions ISO RGD:1614413 6480464 [Cisplatin co-treated with vinorelbine] results in decreased expression of TRAF1 mRNA CTD PMID:21544650 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of TRAF1 mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of TRAF1 mRNA CTD PMID:27392435 , PMID:27594783 copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of TRAF1 mRNA CTD PMID:30911355 copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of TRAF1 mRNA CTD PMID:30911355 crocidolite asbestos affects expression EXP 6480464 Asbestos, Crocidolite affects the expression of TRAF1 mRNA CTD PMID:24160326 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of TRAF1 mRNA CTD PMID:25757056 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [TNF protein results in increased expression of TRAF1 mRNA] CTD PMID:16219905 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of TRAF1 protein CTD PMID:16023083 , PMID:19372569 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of TRAF1 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1614413 6480464 Cyclosporine results in increased expression of TRAF1 mRNA CTD PMID:23958496 delta-tocotrienol multiple interactions ISO RGD:1614413 6480464 tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF1 mRNA] CTD PMID:22185406 delta-tocotrienol increases expression ISO RGD:1614413 6480464 tocotrienol, delta results in increased expression of TRAF1 mRNA CTD PMID:22185406 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of TRAF1 mRNA CTD PMID:22846391 dexamethasone decreases expression ISO RGD:1614413 6480464 Dexamethasone results in decreased expression of TRAF1 mRNA CTD PMID:22185406 dexamethasone multiple interactions ISO RGD:1614413 6480464 Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF1 mRNA] CTD PMID:22185406 diarsenic trioxide increases expression ISO RGD:1596290 6480464 Arsenic Trioxide results in increased expression of TRAF1 mRNA CTD PMID:19730151 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of TRAF1 mRNA CTD PMID:20458559 dioscin increases expression EXP 6480464 dioscin results in increased expression of TRAF1 protein CTD PMID:22334414 dioxygen multiple interactions ISO RGD:1614413 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRAF1 mRNA CTD PMID:30529165 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of TRAF1 mRNA CTD PMID:29803840 endosulfan decreases expression ISO RGD:1596290 6480464 Endosulfan results in decreased expression of TRAF1 mRNA CTD PMID:29391264 folic acid affects expression EXP 6480464 Folic Acid affects the expression of TRAF1 mRNA CTD PMID:16361273 folic acid multiple interactions EXP 6480464 [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of TRAF1 mRNA, [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of TRAF1 mRNA CTD PMID:22975265 , PMID:24657277 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of TRAF1 mRNA CTD PMID:23649840 Fusarenone X increases expression ISO RGD:1614413 6480464 fusarenon-X results in increased expression of TRAF1 mRNA CTD PMID:24983900 gemcitabine affects expression EXP 6480464 gemcitabine affects the expression of TRAF1 mRNA CTD PMID:17039268 guggulsterone multiple interactions EXP 6480464 pregna-4 more ... CTD PMID:15322087 indole-3-methanol multiple interactions EXP 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of TRAF1 protein] CTD PMID:15811958 ionomycin multiple interactions EXP 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA] more ... CTD PMID:15477007 irinotecan increases expression EXP 6480464 Irinotecan metabolite results in increased expression of TRAF1 mRNA, Irinotecan results in increased expression of TRAF1 mRNA CTD PMID:15956246 irinotecan decreases expression EXP 6480464 Irinotecan metabolite results in decreased expression of TRAF1 mRNA, Irinotecan results in decreased expression of TRAF1 mRNA CTD PMID:15956246 lead diacetate decreases expression ISO RGD:1614413 6480464 lead acetate results in decreased expression of TRAF1 mRNA CTD PMID:22609695 lipopolysaccharide multiple interactions ISO RGD:1614413 6480464 +-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF1 mRNA] more ... CTD PMID:22185406 , PMID:25890327 lipopolysaccharide increases expression ISO RGD:1614413 6480464 Lipopolysaccharides results in increased expression of TRAF1 mRNA CTD PMID:22185406 , PMID:25890327 lonafarnib multiple interactions EXP 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of TRAF1 protein] CTD PMID:15090542 methotrexate multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of TRAF1 mRNA CTD PMID:24657277 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of TRAF1 mRNA CTD PMID:24657277 methyl methanesulfonate decreases expression EXP 6480464 Methyl Methanesulfonate results in decreased expression of TRAF1 mRNA CTD PMID:23649840 N-nitrosodiethylamine increases expression ISO RGD:1614413 6480464 Diethylnitrosamine results in increased expression of TRAF1 protein CTD PMID:20583210 N-nitrosodiethylamine multiple interactions ISO RGD:1614413 6480464 CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of TRAF1 protein] CTD PMID:20583210 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of TRAF1 mRNA CTD PMID:16780908 p-menthan-3-ol decreases expression EXP 6480464 Menthol results in decreased expression of TRAF1 mRNA CTD PMID:26760959 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of TRAF1 mRNA CTD PMID:18058816 paracetamol increases expression ISO RGD:1596290 6480464 Acetaminophen results in increased expression of TRAF1 mRNA CTD PMID:30723492 parthenolide multiple interactions EXP 6480464 parthenolide inhibits the reaction [FGF2 protein results in increased expression of TRAF1 mRNA], parthenolide inhibits the reaction [VEGFA protein results in increased expression of TRAF1 mRNA] CTD PMID:16921510 parthenolide decreases expression EXP 6480464 parthenolide results in decreased expression of TRAF1 mRNA, parthenolide results in decreased expression of TRAF1 protein CTD PMID:16921510 pemetrexed multiple interactions EXP 6480464 [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of TRAF1 mRNA CTD PMID:22975265 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA] more ... CTD PMID:15477007 , PMID:21035309 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA] more ... CTD PMID:15477007 quercetin multiple interactions ISO RGD:1614413 6480464 Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF1 mRNA] CTD PMID:22185406 quercetin decreases expression ISO RGD:1614413 6480464 Quercetin results in decreased expression of TRAF1 mRNA CTD PMID:22185406 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of TRAF1 mRNA CTD PMID:15280659 Rhein increases expression EXP 6480464 rhein results in increased expression of TRAF1 protein CTD PMID:31436023 rotenone affects expression ISO RGD:1614413 6480464 Rotenone affects the expression of TRAF1 mRNA CTD PMID:23186747 serpentine asbestos affects expression EXP 6480464 Asbestos, Serpentine affects the expression of TRAF1 mRNA CTD PMID:24160326 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of TRAF1 mRNA, Silicon Dioxide results in increased expression of TRAF1 mRNA CTD PMID:22300531 more ... silicon dioxide increases expression ISO RGD:1614413 6480464 Silicon Dioxide results in increased expression of TRAF1 mRNA CTD PMID:19073995 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of TRAF1 protein CTD PMID:12676792 succimer multiple interactions ISO RGD:1614413 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TRAF1 mRNA CTD PMID:21641980 sulforaphane decreases expression ISO RGD:1614413 6480464 sulforafan results in decreased expression of TRAF1 mRNA CTD PMID:30529165 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of TRAF1 mRNA CTD PMID:31533062 tert-butyl hydroperoxide increases expression ISO RGD:1614413 6480464 tert-Butylhydroperoxide results in increased expression of TRAF1 mRNA CTD PMID:15003993 theophylline decreases expression EXP 6480464 Theophylline results in decreased expression of TRAF1 mRNA CTD PMID:16083514 titanium dioxide decreases expression ISO RGD:1614413 6480464 titanium dioxide results in decreased expression of TRAF1 mRNA CTD PMID:27760801 titanium dioxide increases expression ISO RGD:1614413 6480464 titanium dioxide results in increased expression of TRAF1 mRNA CTD PMID:23557971 urethane decreases expression EXP 6480464 Urethane results in decreased expression of TRAF1 mRNA CTD PMID:28818685 vincristine increases expression EXP 6480464 Vincristine results in increased expression of TRAF1 mRNA CTD PMID:23649840 vinorelbine multiple interactions ISO RGD:1614413 6480464 [Cisplatin co-treated with vinorelbine] results in decreased expression of TRAF1 mRNA CTD PMID:21544650 vorinostat multiple interactions EXP 6480464 vorinostat inhibits the reaction [TNF protein results in increased expression of TRAF1 protein] CTD PMID:16377638 zerumbone decreases expression EXP 6480464 zerumbone results in decreased expression of TRAF1 mRNA CTD PMID:16007145 zinc atom multiple interactions EXP 6480464 Zinc promotes the reaction [Tetradecanoylphorbol Acetate promotes the reaction [TRAF1 protein binds to TNFAIP3 protein]] CTD PMID:21035309 zinc(0) multiple interactions EXP 6480464 Zinc promotes the reaction [Tetradecanoylphorbol Acetate promotes the reaction [TRAF1 protein binds to TNFAIP3 protein]] CTD PMID:21035309